DBV TECHNOLOGIES SA-SPON ADR (DBVT) Stock News
NASDAQ:DBVT - Nasdaq - US23306J2006 - ADR - Currency: USD
DBVT Latest News, Press Relases and Analysis
Top movers in Tuesday's session
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
Information regarding the total number of voting rights and total number of shares of the Company...
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 mai 2025
...
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies...
DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV...
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
Are Medical Stocks Lagging DBV Technologies (DBVT) This Year?
Here is how DBV Technologies S.A. (DBVT) and Hims & Hers Health, Inc. (HIMS) have performed compared to their sector so far this year.
Mentions: HIMS
Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A. (DBVT) is a Great Choice
Does DBV Technologies S.A. (DBVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
DBV Technologies (DBVT) Is a Great Choice for 'Trend' Investors, Here's Why
DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Combined General Meeting of June 11, 2025
Combined General Meeting of June 11, 2025
Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined...
Assemblée Générale Mixte du 11 juin 2025
Châtillon, France, le 15 mai 2025 Assemblée Générale Mixte du 11 juin 2025 Modalités de mise à disposition des informations et documents préparatoires à...
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025 (Article 223-16 of the General...
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025 (Article 223-16 du Règlement Général de...
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN:...
DBV Technologies participera à la conférence Citizens JMP Life Sciences
Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV...
DBV Technologies Reports First Quarter 2025 Financial Results
DBV Technologies Reports First Quarter 2025 Financial Results
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345...
DBV Technologies publie ses résultats financiers du 1er trimestre 2025
Châtillon, France, le 30 avril (22 :00 CEST) 2025 DBV Technologies publie ses résultats financiers du 1er trimestre 2025 DBV Technologies (Euronext :...
Why DBV Technologies S.A. (DBVT) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where DBV Technologies S.A. (NASDAQ:DBVT) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
Châtillon, France, April 11, 2025 DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document DBV...
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024
Châtillon, France, le 11 avril 2025 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024 DBV Technologies...
3 Biopharmaceutical Stocks Bucking the Sell-Off
Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.
DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros) permettant d’avancer le programme Viaskin® Peanut jusqu’au dépôt d'une Demande de Licence Biologique (BLA) et d’assurer la...
Châtillon, France, le 28 mars (3h30 CET) 2025 DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros)...